Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01636518

Hybrid AF -- A Prospective Registry

Hybrid Procedure for the Treatment of Long Standing Persistent Atrial Fibrillation - A Prospective Registry

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Dhanunjaya Lakkireddy, MD, FACC · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Atrial Fibrillation (AF) is a form of rapid irregular heart rhythm that starts in the upper chambers of the heart (called atria) and is often associated with many health problems. It can cause stroke, palpitations and heart failure. The management of long standing (chronic) AF may require additional medications and blood thinners, potentially for life. It may also require procedures where the heart is shocked with an electrical current to restore normal rhythm. Some patients require a procedure called radiofrequency ablation to address the arrhythmia. The purpose of this registry is to collect information on patients undergoing this combination of procedures into a database, and to then use this information for scientific study to improve the treatment of atrial fibrillation.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard of CareStandard of care procedure as determined by treating physician for Atrial Fibrillation

Timeline

Start date
2012-07-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2012-07-10
Last updated
2015-04-22

Source: ClinicalTrials.gov record NCT01636518. Inclusion in this directory is not an endorsement.